News & insights

Supreme Court ruling on penalty clauses: consequences for bad leaver provisions

by Debbie Cloake

Upgrading the single market: a unitary SPC?

by Dr Paul England

Strategic considerations - why opt-out or why not?

by Dr. Anja Lunze, LL.M.

Pharmaceutical trade mark confusion

Using intellectual property protection

by Colin McCall

EU Commission regulates post-authorisation efficacy studies ("PAES")

by Dr. Wolfgang Rehmann

Personalised medicine – challenges of authorisation and reimbursement

by Dr. Manja Epping

There is more than one way to extend data exclusivity periods

by Edward Vickers

Companion diagnostics: legislation in progress

by Dr. Manja Epping